Date published: 2026-4-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Rifapentine (CAS 61379-65-5)

5.0(1)
Write a reviewAsk a question

See product citations (1)

Application:
Rifapentine is an antibiotic
CAS Number:
61379-65-5
Purity:
≥98%
Molecular Weight:
877.03
Molecular Formula:
C47H64N4O12
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Rifapentine, with CAS number 61379-65-5, is a chemical derivative of rifamycin, designed to study the inhibition of bacterial RNA synthesis, particularly in research focused on understanding and preventing bacterial transcription processes. The primary mechanism of action for Rifapentine involves the inhibition of DNA-dependent RNA polymerase in bacterial cells. By binding to the beta subunit of this enzyme, Rifapentine effectively blocks RNA synthesis, preventing the transcription of DNA into RNA. This disruption halts the production of essential proteins needed for bacterial growth and replication. In the realm of research, Rifapentine has been pivotal in exploring the dynamics of transcription inhibition in bacteria and the subsequent effects on cellular processes. Studies involving this compound help to map out the genetic pathways affected by transcriptional inhibitors and to understand the molecular basis of action and resistance. Furthermore, research utilizing Rifapentine has been instrumental in examining the rate of mutation that leads to resistance, providing insights into the evolutionary aspects of bacterial adaptation to environmental stresses, including inhibitor presence. These studies contribute to a broader understanding of microbial genetics and can inform strategies for managing bacterial populations in various ecological and industrial settings.


Rifapentine (CAS 61379-65-5) References

  1. Effectiveness of once-weekly rifapentine and moxifloxacin regimens against Mycobacterium tuberculosis in mice.  |  Lounis, N., et al. 2001. Antimicrob Agents Chemother. 45: 3482-6. PMID: 11709328
  2. Activity of rifapentine against Mycobacterium avium infection in beige mice.  |  Klemens, SP. and Cynamon, MH. 1992. J Antimicrob Chemother. 29: 555-61. PMID: 1624393
  3. Murine pharmacokinetics of rifapentine delivered as an inhalable dry powder.  |  Chan, JG., et al. 2015. Int J Antimicrob Agents. 45: 319-23. PMID: 25554469
  4. Inhalation of Respirable Crystalline Rifapentine Particles Induces Pulmonary Inflammation.  |  Parumasivam, T., et al. 2017. Mol Pharm. 14: 328-335. PMID: 27977216
  5. Pharmacokinetics of rifapentine, a new long lasting rifamycin, in the rat, the mouse and the rabbit.  |  Assandri, A., et al. 1984. J Antibiot (Tokyo). 37: 1066-75. PMID: 6501103
  6. Antibacterial activity of DL 473, a C3-substituted rifamycin derivative.  |  Neu, HC. 1983. Antimicrob Agents Chemother. 24: 457-60. PMID: 6639006
  7. Antibacterial activity of DL 473, a new semisynthetic rifamycin derivative.  |  Arioli, V., et al. 1981. J Antibiot (Tokyo). 34: 1026-32. PMID: 7319918
  8. Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice.  |  Chapuis, L., et al. 1994. Am J Respir Crit Care Med. 150: 1355-62. PMID: 7952564
  9. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.  |  Emary, WB., et al. 1998. Drug Metab Dispos. 26: 725-31. PMID: 9698285
  10. Rifapentine.  |  Jarvis, B. and Lamb, HM. 1998. Drugs. 56: 607-16; discussion 617. PMID: 9806107

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Rifapentine, 10 mg

sc-212785
10 mg
$183.00